Hi Fools: Only Buyer possible J&J at right price

Quote


















Anonymous said:
Will there be lay offs? If the company is sold? I want to know the truth! My manager says lots of work and new projects are lined up that i should not worry
Click to expand...

Good Question. The new company will look at the new projects and work and determine whether the projects are worth funding. Most will likely be cut as the new company will have either their own projects to fund or may not like the project you are working on.

This means a high probability of layoffs when the company is sold.
 






Based on this analysis J&J, Abbott etc. want the parts but not the whole. WP should consider whether they can make a profit by selling the parts to different companies.
 






You are right about selling the parts. The analysis says that B+L does not fit J&J, or Abbotts business model. It was the CEO and Chairman's job for the last few years to get B+L organization into a sellable company. If the company can not be sold into the three logical separate business units to make the same price as selling the whole thing than the CEO and chairman did not do their jobs.

The seller should meet the buyers needs. To expect these companies to buy business units that they do not need is asking too much. Sell the Pharma unit to pfizer for 4 billion, the Vision Care unit to J&J for 4 billion, and the surgical business to Metronics for 2 billion. This type of deal is why the CEO and chairman get paid the big bucks. WP should demand that the management explain why the business units can not be sold separately and if not reorganize the company so that they can.
 






Anonymous said:
You are right about selling the parts. The analysis says that B+L does not fit J&J, or Abbotts business model. It was the CEO and Chairman's job for the last few years to get B+L organization into a sellable company. If the company can not be sold into the three logical separate business units to make the same price as selling the whole thing than the CEO and chairman did not do their jobs.

The seller should meet the buyers needs. To expect these companies to buy business units that they do not need is asking too much. Sell the Pharma unit to pfizer for 4 billion, the Vision Care unit to J&J for 4 billion, and the surgical business to Metronics for 2 billion. This type of deal is why the CEO and chairman get paid the big bucks. WP should demand that the management explain why the business units can not be sold separately and if not reorganize the company so that they can.
Click to expand...

Too much tax implication to sell in parts. It would kill the profit margin and they would have to demand more money.
 












if another company buys you, of course there will be layoffs you dumb monkey. so much redundancy in B&L not to mention at another company across all divisions. if the company has no ophthalmic presence, maybe sales would not be touched, that's a pipe dream that a company would divest into ophthalmics now. Most likely a company looking to consolidate ophthalmics into fewer companies will buy some or all of B&L, but if they have an ophthalmic division, sales would be wiped out. just like you just did to ista

no one is buying b&L for 10 billion. would be the business blunder of the decade.
 












Top Bottom
Back
Quote